The way property values are displayed:
The way concept relations are shown:
The way concept relations are shown:
Antibodies, Bispecific
Hierarchy: | ∟ ∟ ∟ ∟ ∟ ∟ ∟ Antibodies, Bispecific 32 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Antibodies, Bispecific 32 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Antibodies, Bispecific 32 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ |
Broader terms: | |
Annotation: | do not coordinate with ANTIBODY FORMATION for /biosyn
X |
History note: | |
historyNote*: | 94
X |
publicMeSHNote*: | 94
X |
Scope note: | Antibodies, often monoclonal, in which the two antigen-binding sites are specific for separate ANTIGENIC DETERMINANTS. They are artificial antibodies produced by chemical crosslinking, fusion of HYBRIDOMA cells, or by molecular genetic techniques. They function as the main mediators of targeted cellular cytotoxicity and have been shown to be efficient in the targeting of drugs, toxins, radiolabeled haptens, and effector cells to diseased tissue, primarily tumors.
X |
activeMeSHYear*: | |
dateCreated*: | 1993-06-04X |
dateEstablished*: | 1994-01-01X |
dateRevised*: | 2005-06-30X |
recordAuthorizer*: | sjnX |
recordMaintainer*: | ssbX |
recordOriginator*: | AGSX |
Related term: | |
Type: | |
Coordinate terms: | |
URI: | |
Labels and equivalent concepts: | Bispesifiset vasta-aineet (fi) XBispesifinen vasta-aine (fi, replaced) Antikroppar med dubbel specificitet (sv) Bispecific Antibodies (en, replaced) Bifunctional Antibodies (en, replaced) |
Share: |
Loading results...